Necklall Khooblall, MD
Internal Medicine · Austintown, OHNPI 1225015506
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $447,819 of the $447,845 with a category attached, or 100.0%. 4 manufacturers reported payments, led by CSL Behring at 37.8% of the total. 2025 is the largest year on record at $114,880, 3.6 times the $32,280 reported in 2019. Among internal medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 504 payments — averaging $888.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$169K
- Kedplasma LLC$142K
- CSL Plasma Inc.$137K
- Evoke Pharma, Inc.$26
What the payments were for
- Consulting fees$447,819100%
- Food & beverage$260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 199 | $169,267 |
| Kedplasma LLC | 88 | $141,593 |
| CSL Plasma Inc. | 215 | $136,960 |
| Evoke Pharma, Inc. | 2 | $26 |
How this compares
$447,845 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $47,331 |
| JardianceEmpagliflozin | 40 | $35,730 |
| MounjaroTirzepatide | 12 | $12,502 |
| EliquisApixaban | 12 | $7,331 |
| EntrestoSacubitril/Valsartan | 20 | $6,597 |
| XareltoRivaroxaban | 12 | $6,539 |
| Bumetanide | 67 | $2,880 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 98 | $2,347 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,311 |
| Atorvastatin Calcium | 147 | $1,679 |
| Losartan Potassium | 131 | $1,535 |
| Midodrine Hcl | 16 | $1,442 |
| Pravastatin Sodium | 73 | $1,398 |
| Clorazepate Dipotassium | 21 | $1,373 |
| Amlodipine Besylate | 218 | $1,278 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Austintown
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
- Amy HiteAkron$253K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.